Search

Answering the biggest questions in secondary breast cancer research

When breast cancer spreads around the body, it's called secondary breast cancer. It can be treated, but it currently can't be cured. Our research could help buy more time so people can live their lives to the fullest for as long as possible. Here, we’ll go over some of the biggest questions in secondary breast cancer research. And how our researchers are working on answering them.

We respond to NICE’s approval of trastuzumab deruxtecan (Enhertu) for use on the Cancer Drugs Fund

Chief Executive of Breast Cancer Now, Baroness Delyth Morgan, has commented on NICE'S decision to approve trastuzumab deruxtecan for use on the Cancer Drugs Fund.

Rav- diet myths and recurrence - Breast Cancer Now Podcast

We discuss diet, which can cause a lot of confusion and anxiety for women who are worried about their risk of breast cancer or the chance of it coming back. Our nurse Addie speaks to Rav, a dietician at the Royal Marsden hospital. They chat about diet myths and breast cancer risk and recurrence, diet advice during and after treatment, and how to get referred to a dietician.

Valerie’s callaloo and lentil pasties

Looking for a delicious savoury treat for your Afternoon Tea? Why not try Valerie’s callaloo and lentil pasties - your guests will love them!

Improving our understanding of how triple negative breast cancer responds to treatment

Dr Stephen Sammut

Breast Cancer Now responds to the decision by NICE to provisionally reject talazoparib (Talzenna)

Baroness Delyth Morgan, chief executive of Breast Cancer Now, said:

Breast Cancer Now responds to latest vacancy rates among screening mammographers

Responding to the latest vacancy rates among screening mammographers, Rachael Franklin, interim chief executive at Breast Cancer Now, said:

Delivering our secondary breast cancer petition to the Cancer Minister

Last week, we went to Parliament to deliver our secondary breast cancer petition to the Cancer Minister, Jo Churchill MP.

New research to investigate why breastfeeding reduces the risk of developing breast cancer

Researchers will investigate the relationship between breastfeeding and breast cancer, thanks to new funding from Breast Cancer Now.

Cost of breast cancer to UK economy set to rise up to £4.2 billion in 2050 unless urgent action taken, new Demos research shows

The annual cost of breast cancer to the UK economy could rise by up to 31% to £4.2 billion in 2050, a new report, published by cross-party think tank Demos and leading research and support charity Breast Cancer Now has revealed.[1]

I want to make sure that future generations have a better experience of breast cancer

As a Breast Cancer Voice, Almona focuses on making sure equality, diversity and inclusion are a priority in everything we do as a charity. She tells us about 2 recent projects she’s been involved in, and how she's found a sense of purpose as a Voice.